Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)

Ahn-Gook Pharmaceutical Revenue

Ahn-Gook Pharmaceutical had revenue of 91.85B KRW in the quarter ending June 30, 2026, with 19.56% growth. This brings the company's total for the last twelve months to 345.08B, up 18.68% year-over-year. In the year 2025, Ahn-Gook Pharmaceutical had annual revenue of 306.87B with 13.19% growth. That makes Ahn-Gook Pharmaceutical the 15,512th largest company in the world by revenue and 774th in South Korea.

• Revenue (ttm): 345.08B
• Revenue Growth: +18.68%
• P/S Ratio: 0.30
• Revenue / Employee: 882.55M
• Employees: 391
• Market Cap: 105.13B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 303.50B 98.9%
• Overseas 3.37B 1.1%

Fiscal year ended Dec 31, 2025 See the full Ahn-Gook Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	306.87B	35.76B	13.19%
Dec 31, 2024	271.12B	37.44B	16.02%
Dec 31, 2023	233.68B	28.29B	13.77%
Dec 31, 2022	205.39B	41.85B	25.59%
Dec 31, 2021	163.53B	20.17B	14.07%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error